Preliminary studies the effects of bitter leaf capsules in COVID19 patients

Treatment of COVID19 is still in the research or trial phase. The use of herbs is also being researched at present in various countries and regions. Sambiloto is one of the plants that has been investigated in vitro as a protease inhibitor and anti-inflammatory so it needs to be examined for its use in COVID patients19. To prove the therapeutic effect, a limited trial was performed on COVID19 patients as a supplement of bitter leaf powder in Bali and packaged in capsules.